Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
29 April 2024 - P1828
The production of OXA-2/10 ß-lactamases is a risk factor for resistance development to ceftolozane/tazobactam and ceftazidime/avibactam during the treatment of Pseudomonas aeruginosa infections
Inmaculada López Montesinos, Almudena Fernández-Muñoz, Sonia Luque, Carla López-Causapé, Ma Asunción Colomar Ferra, María Luisa Martín Peña, Silvia Castañeda, Silvia Gómez-Zorrilla, Luisa Sorlí, María Milagro Montero, Eduardo Padilla León, Santiago Grau, Juan Pablo Horcajada, Antonio Oliver Palomo
28 April 2024 - P2457
Mechanism-based mathematical modelling predicts the effects of ciprofloxacin and meropenem on Pseudomonas aeruginosa with different resistance mechanisms in cases where PK/PD indices cannot
Alice Terrill, Kate Rogers, Carla López-Causapé, Wee Leng Lee, Roger L. Nation, Jiangning Song, Antonio Oliver, Cornelia B. Landersdorfer
28 April 2024 - E0548
Mechanism-based modelling approach to simultaneously characterise the effects of single and multiple resistance mechanisms on bacterial killing and resistance emergence of Pseudomonas aeruginosa in response to meropenem
Dominika Fuhs, Sara Cortés-Lara, Jessica Tait, Kate Rogers, Carla López-Causapé, Wee Leng Lee, Roger L. Nation, Antonio Oliver, Cornelia B. Landersdorfer
28 April 2024 - P2314
Ciprofloxacin-aztreonam combination provides synergistic killing against Pseudomonas aeruginosa PAO1 and isogenic strains showing AmpC or MexAB-OprM hyperproduction
Jessica Tait, Han B. Le, Cameron J. Nowell, Kate Rogers, Wee Leng Lee, Carla López-Causapé, Roger L. Nation, Antonio Oliver, Cornelia B. Landersdorfer
28 April 2024 - E0549
Ceftolozane/tazobactam and meropenem, in monotherapy and combination, against ST235 clone Pseudomonas aeruginosa isolates in the dynamic In vitro hollow-fibre infection model
Siobhonne Breen, Kate Rogers, Wee Leng Lee, Megan Faith, Jessica Tait, Alice Terrill, Carla López-Causapé, Roger L. Nation, Antonio Oliver, Cornelia B. Landersdorfer,
28 April 2024 - P2286
Filamentous phages and its role in the phage defence in CF isolates of P. aeruginosa
Lucia Blasco, Carla López-Causapé, Maria López, Ines Bleriot, Olga Pacios Santamaría, Laura Fernández-Garcia, Concha Ortiz-Cartagena, Antonio Barrio-Pujante, Rafael Cantón, Antonio Oliver, María Tomás
28 April 2024 - P2362
In vitro evaluation of cefiderocol and the combination of ceftazidime/avibactam and aztreonam, against extensively drug-resistant Pseudomonas aeruginosa isolates producing serine and metallo-β-lactamases
María Milagro Montero, Sandra Domene-Ochoa, Núria Prim, Eliana Ferola, Carla López-Causapé, Daniel Echeverría-Esnal, Luisa Sorli, Sonia Luque, Eduardo Padilla León, Santiago Grau, Antonio Oliver, Juan Pablo Horcajada
27 April 2024 - P2251
Quorum sensing molecular signatures to diagnose P. aeruginosa infections
Juan Raya, Marc Alorda, Nuria Pascual, María Teresa Martín-Gómez, Juan Pablo Horcajada, Carla López-Causapé, Antonio Oliver, M.-Pilar Marco
18 April 2023 - E1248
Antimicrobial susceptibility profile of Campylobacter jejuni and Campylobacter coli isolates during a 10-year period: characterisation of multi-drug resistant isolates using whole genome sequencing
Santiago Pérez-Vázquez, Biel Taltavull, Carla López-Causapé, Xavier Mulet, Antonio Oliver, Ana Mena
18 April 2023 - E1173
Real-time monitoring of Pseudomonas aeruginosa mutational resistome using an enrichment panel for direct sequencing of clinical samples
Sara Cortés-Lara, Paola Medina-Reatiga, Ester Del Barrio-Tofiño, Carla Iglesias, Asun Colomar, Ignacio Ayestarán, Carla López-Causapé, Antonio Oliver
17 April 2023 - P2230
Meropenem and ciprofloxacin combination regimens against isogenic Pseudomonas aeruginosa strains with different resistance mechanisms in a dynamic hollow fibre model
Alice Terrill, Kate Rogers, Carla López-Causapé, Wee Lee, Roger Nation, Antonio Oliver, Cornelia Landersdorfer
17 April 2023 - P2231
Evaluation of apotransferrin in combination with ceftolozane/tazobactam as an innovative therapy in extensively resistant Pseudomonas aeruginosa infections in an in vitro PK/PD model
Maria Milagro Montero, Sandra Domene-Ochoa, Dani Echeverría-Esnal, Carla López-Causapé, Sonia Luque, Luisa Sorli, Inmaculada López-Montesinos, Eduardo Padilla, Núria Prim, Santiago Grau, Antonio Oliver, Juan Pablo Horcajada
15 April 2023 - O0258
Effect of different resistance mechanisms on bacterial killing and resistance emergence of Pseudomonas aeruginosa in response to meropenem dosing regimens in a hollow fibre model
Kate Rogers, Carla López-Causapé, Wee Lee, Roger Nation, Antonio Oliver, Cornelia Landersdorfer
15 April 2023 - P0141
Molecular epidemiology and resistance genomics of carbapenemase-producing Enterobacter cloacae complex detected in the Balearic Islands (Spain) from 2018 to 2021
Estrella Rojo-Molinero, Carla López-Causapé, Margarita Garau, Olivia Gutiérrez, Susana M Ramón, Albert Bas, Rocio Rodriguez, Sara Cortés-Lara, Xavier Mulet
14 September 2022 - P2-91
Whole genome sequencing-based characterization of Carbapenemase-producing Enterobacteriaceae (CPE) detected in the Balearic Islands (Spain) during 2021
Estrella Rojo-Molinero, Carla López-Causapé, Margarita Garau, Olivia Gutiérrez, Susana M Ramón, Elena Riera, Eva M Roselló, Cristina Norte, Maria Gaya, Sara Fernández-Ruiz, Ricardo Manuel Arcay, Rocío Rodríguez, Sara Cortés-Lara, Xavier Mulet, Jesús Oteo, Antonio Oliver
23 April 2022 - P1351
Effect of different resistance mechanisms on bacterial killing and regrowth of Pseudomonas aeruginosa in response to meropenem
Alice Terrill, Kate Rogers, Carla López-Causapé, Wee Leng Lee, Roger Nation, Antonio Oliver, Cornelia Landersdorfer
23 April 2022 - P0250
Efficacy of dual carbapenem treatment in a murine sepsis model of infection due to carbapenemase-producing Pseudomonas aeruginosa clinical isolates
Soraya Herrera-Espejo, Ester Del Barrio-Tofiño, Tania Cebrero-Cangueiro, Carla López-Causapé, Rocío Álvarez-Marín, Jerónimo Pachón, Antonio Oliver, María Eugenia Pachón-Ibáñez
23 April 2022 - P1850
Changes in the lipidome of plasma exosomes and in the gut microbiota may reflect the status of Clostridioides difficile infection
Ricardo M. Arcay, Loreto Suárez-Bode, Luisa Martín, Rebeca Reigada, María Barceló-Nicolau, Carmen Garrido, Carla López-Causapé, Antonio Oliver, Gwendolyn Barceló-Coblijn, Ana Mena
23 April 2022 - P0764
In vitro activity of cefiderocol and comparator antimicrobials in a collection of Pseudomonas aeruginosa isolates recovered from people with cystic fibrosis during two Spanish multi-centre studies (2013-2021)
Ainhize Maruri-Aransolo, Carla López-Causapé, Juan De Dios Caballero, María García-Castillo, Ivan Penev, Desirèe Gijón-Cordero, Xavier Mulet, Rosa Del Campo, Antonio Oliver, Rafael Cantón
23 April 2022 - P0759
In vitro activity of cefiderocol and comparator antimicrobials in a collection of Pseudomonas aeruginosa isolates recovered from people with cystic fibrosis during two Spanish multi-centre studies (2013-2021)
Ainhize Maruri-Aransolo, Carla López-Causapé, Juan De Dios Caballero, María García-Castillo, Ivan Penev, Desirèe Gijón-Cordero, Xavier Mulet, Rosa Del Campo, Antonio Oliver, Rafael Cantón
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.